These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 26506270)

  • 1. Results of the ROADSTER multicenter trial of transcarotid stenting with dynamic flow reversal.
    Kwolek CJ; Jaff MR; Leal JI; Hopkins LN; Shah RM; Hanover TM; Macdonald S; Cambria RP
    J Vasc Surg; 2015 Nov; 62(5):1227-34. PubMed ID: 26506270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the ROADSTER pivotal and extended-access cohorts shows excellent 1-year durability of transcarotid stenting with dynamic flow reversal.
    Malas MB; Leal Lorenzo JI; Nejim B; Hanover TM; Mehta M; Kashyap V; Kwolek CJ; Cambria R
    J Vasc Surg; 2019 Jun; 69(6):1786-1796. PubMed ID: 30611582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and feasibility of a novel transcervical access neuroprotection system for carotid artery stenting in the PROOF Study.
    Pinter L; Ribo M; Loh C; Lane B; Roberts T; Chou TM; Kolvenbach RR
    J Vasc Surg; 2011 Nov; 54(5):1317-23. PubMed ID: 21658889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technical aspects of transcarotid artery revascularization using the ENROUTE transcarotid neuroprotection and stent system.
    Malas MB; Leal J; Kashyap V; Cambria RP; Kwolek CJ; Criado E
    J Vasc Surg; 2017 Mar; 65(3):916-920. PubMed ID: 28236931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes associated with a transcarotid artery revascularization-centered protocol in high-risk carotid revascularizations using the ENROUTE neuroprotection system.
    Wang SK; Fajardo A; Sawchuk AP; Lemmon GW; Dalsing MC; Gupta AK; Murphy MP; Motaganahalli RL
    J Vasc Surg; 2019 Mar; 69(3):807-813. PubMed ID: 30301690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Outcomes in the ROADSTER 2 Study of Transcarotid Artery Revascularization in Patients With Significant Carotid Artery Disease.
    Kashyap VS; Schneider PA; Foteh M; Motaganahalli R; Shah R; Eckstein HH; Henao S; LaMuraglia G; Stoner MC; Melton J; Massop D; Hanover T; Titus J; Moore WS; Rodríguez-Carvajal R; Malas MB; Arko FR; Pierce D; Anain P; Oskin T;
    Stroke; 2020 Sep; 51(9):2620-2629. PubMed ID: 32811386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcarotid Artery Revascularization With Flow Reversal.
    Alpaslan A; Wintermark M; Pintér L; Macdonald S; Ruedy R; Kolvenbach R
    J Endovasc Ther; 2017 Apr; 24(2):265-270. PubMed ID: 28335706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endovascular stenting of supra-aortic lesions using a transcarotid retrograde approach and flow reversal: A multicenter case series.
    Balceniuk MD; Hosn MA; Corn RS; DerDerian T; Grimsley BR; Long P; Moore WS; Rossi PJ; Shakir HJ; Siddiqui AH; Spadone DP; Waqas M; Stoner MC
    J Vasc Surg; 2020 Jun; 71(6):2012-2020.e18. PubMed ID: 31740187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporary Reversal of Blood Flow During Transcarotid Artery Revascularization Does Not Change Brain Electrical Activity in Lead-In Cases of the ROADSTER 1 Multicenter Trial.
    King AH; Motaganahalli RL; Siddiqui A; DeRubertis B; Moore WS; DiMuzio P; Eccher MA; Kashyap VS
    J Endovasc Ther; 2018 Dec; 25(6):773-778. PubMed ID: 30191765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and effectiveness of the INVATEC MO.MA proximal cerebral protection device during carotid artery stenting: results from the ARMOUR pivotal trial.
    Ansel GM; Hopkins LN; Jaff MR; Rubino P; Bacharach JM; Scheinert D; Myla S; Das T; Cremonesi A;
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):1-8. PubMed ID: 20222019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential outcomes of carotid stenting and endarterectomy performed exclusively by vascular surgeons in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST).
    Timaran CH; Mantese VA; Malas M; Brown OW; Lal BK; Moore WS; Voeks JH; Brott TG;
    J Vasc Surg; 2013 Feb; 57(2):303-8. PubMed ID: 23265585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective, multicenter European study of the GORE flow reversal system for providing neuroprotection during carotid artery stenting.
    Nikas D; Reith W; Schmidt A; Duda S; Mathias K; Cremonesi A; Dill H; Formgren J; Pieniazek P; Musialek P; Hornung M; Sievert H; Reimers B
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1060-8. PubMed ID: 22644906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary mechanism of stroke reduction in transcarotid artery revascularization is dynamic flow reversal.
    Naazie IN; Magee GA; Mathlouthi A; Elsayed N; Dakour-Aridi H; Malas MB
    J Vasc Surg; 2021 Jul; 74(1):187-194. PubMed ID: 33276041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of blood flow reversal during transcarotid artery revascularization does not affect outcome.
    Kumins NH; King AH; Jim J; Motaganahalli RL; Apple JM; Foteh MI; Cho JS; Kashyap VS
    J Vasc Surg; 2020 Aug; 72(2):584-588. PubMed ID: 31901361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carotid artery stenting and patient outcomes: the CABANA surveillance study.
    Hopkins LN; White CJ; Foster MT; Powell RJ; Zemel G; Diaz-Cartelle J
    Catheter Cardiovasc Interv; 2014 Nov; 84(6):997-1004. PubMed ID: 24948033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Carotid Revascularization Endarterectomy vs. Stenting Trial completes randomization: lessons learned and anticipated results.
    Lal BK; Brott TG
    J Vasc Surg; 2009 Nov; 50(5):1224-31. PubMed ID: 19878793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of carotid artery stenting with distal embolic protection with improved systems: Protected Carotid Artery Stenting in Patients at High Risk for Carotid Endarterectomy (PROTECT) trial.
    Matsumura JS; Gray W; Chaturvedi S; Yamanouchi D; Peng L; Verta P
    J Vasc Surg; 2012 Apr; 55(4):968-976.e5. PubMed ID: 22236885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CAPTURE 2 risk-adjusted stroke outcome benchmarks for carotid artery stenting with distal embolic protection.
    Matsumura JS; Gray W; Chaturvedi S; Gao X; Cheng J; Verta P;
    J Vasc Surg; 2010 Sep; 52(3):576-83, 583.e1-583.e2. PubMed ID: 20576398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carotid revascularization outcomes comparing distal filters, flow reversal, and endarterectomy.
    Brewster LP; Beaulieu R; Corriere MA; Veeraswamy R; Niazi KA; Robertson G; Dodson TF; Kasirajan K
    J Vasc Surg; 2011 Oct; 54(4):1000-4; discussion 1004-5. PubMed ID: 21871772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection during carotid artery stenting using the GORE flow reversal system: 30-day outcomes in the EMPiRE Clinical Study.
    Clair DG; Hopkins LN; Mehta M; Kasirajan K; Schermerhorn M; Schönholz C; Kwolek CJ; Eskandari MK; Powell RJ; Ansel GM;
    Catheter Cardiovasc Interv; 2011 Feb; 77(3):420-9. PubMed ID: 20853365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.